According to a Care Quality Commission (CQC) publication, unlicensed medical cannabis prescribing in the private healthcare sector increased by 935% from 2020 to 2021 with 15 providers that offer unlicensed cannabis-based products for medicinal use registered and more being assessed.
The recent report Safer management of controlled drugs: Annual update 2021” noted there were 37,634 items prescribed between January and November 2021 by non-NHS healthcare services as compared with 3,636 items prescribed between January and November 2020.
By contrast, over the same period of time, the National Health Services (NHS) CBMPs prescribing in England was so low that data could not be reported. “The number of items prescribed within the NHS is so small that this could potentially affect patient confidentiality,” reads the report.
– Read the entire article at Benzinga.